Canine distemper virus vaccine
AssigneeDiamond Scientific Co.
InventorsEdmund P. Bass, William H. Kelsey, Michael D. McFarland
Life of this patent
Estimating the term…
Abstract
A vaccine composition for animals susceptible to infection by canine distemper virus. The vaccine comprises a small but immunologically effective amount of an inactivated canine distemper virus in combination with a non-toxic pharmaceutically acceptable immunologic adjuvant. A preferred method of inactivation of canine distemper virus by either exposure of the virus to an inactivating effective amount of binary ethyleneimine or alternatively exposure of the virus to long wavelength ultraviolet light in the presence of a furocoumarin.
Claims13
A vaccine composition for animals susceptible to infection by canine distemper virus (CDV), comprising:
- a small but immunologically effective amount of an inactivated canine distemper virus which although inactivated substantially retains its immunogenicity;
- and
- a non-toxic pharmaceutically acceptable immunologic adjuvant.
The method for protecting mammals from infection caused by canine distemper virus comprising:
- administering to said mammal a vaccine composition containing a small but immunologically effective amount of an inactivated canine distemper virus which although inactivated substantially retains its immunogenicity, said inactivated virus being in combination with a non-toxic pharmaceutically acceptable immunologic adjuvant.
Dependencies are inferred from the claim text.